 |
|
|
| |
The cumulative prevalence and incidence of extra-hepatic manifestations in patients with hepatitis C virus infection: real-world evidence from the United States
|
| |
| |
Reported by Jules Levin
EASL 2017 April 19-23 Amsterdam Netherlands
Nancy Reau1, Francis Vekeman2, Eric Wu2, Yanjun Bao3, Yuri Sanchez Gonzalez3
1Rush University Medical Center, Chicago, IL; 2Analysis Group, Inc., Boston, MA; 3AbbVie Inc., North Chicago, IL, USA
|
| |
|
|
|
|
|
